EPIQ Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
EPIQ Partners's JNJ Position: Q3 2026 in Review
EPIQ Partners reduced its Johnson & Johnson (JNJ) stake by 0.44% in Q3 2026, selling an estimated $10.6K and leaving 8,980 shares worth $2.38M. The position accounts for 1.02% of the portfolio, ranked #28.
EPIQ Partners first reported a position in JNJ in Q4 2019 and has held it in 28 quarters since. The position peaked at $3.3M in Q2 2023. 1,611 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.
- EPIQ Partners held 8,980 shares of Johnson & Johnson worth $2.38M as of Q3 2026.
- EPIQ Partners sold 40 Johnson & Johnson shares in Q3 2026, an estimated $10.6K.
- Johnson & Johnson made up 1.02% of EPIQ Partners's portfolio in Q3 2026, its #28 holding.
- EPIQ Partners first reported a position in Johnson & Johnson in Q4 2019 and has held it in 28 quarters since.
- EPIQ Partners's Johnson & Johnson position peaked at $3.3M in Q2 2023.
- 1,611 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.
Based on EPIQ Partners's 13F filing for Q3 2026, filed 7 Oct 2026.